Abstract
Cardiorenal syndrome type 2 (CRS2) is defined as a chronic cardiovascular disease, usually chronic heart failure (CHF), resulting in chronic kidney disease. We hypothesized that the cardiac spinal afferent reflex (CSAR) plays a critical role in the development of CRS2. Our data suggest that cardiac afferent ablation by resiniferatoxin not only improves cardiac function but also benefits the kidneys and increases long-term survival in the myocardial infarction model of CHF. We also found that renal denervation has a similar reno-protective effect in CHF rats. We believe this novel work contributes to the development of a unique neuromodulation therapy to treat CHF patients.
Original language | English (US) |
---|---|
Pages (from-to) | 582-596 |
Number of pages | 15 |
Journal | JACC: Basic to Translational Science |
Volume | 7 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2022 |
Keywords
- cardiorenal syndrome type 2
- cardiovascular reflexes
- chronic heart failure
- inflammation
- renal failure
- sympathoexcitation
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine